Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System.
Laurel H MesserGregory P ForlenzaJennifer L SherrR Paul WadwaBruce A BuckinghamStuart A WeinzimerDavid M MaahsRobert H SloverPublished in: Diabetes care (2018)
In transitioning young patients to the 670G system, providers should anticipate immediate C-to-I ratio adjustments while also assessing active insulin time. Users should anticipate occasional Auto Mode exits, which can be reduced by following system instructions and reliably bolusing for meals. Unique 670G system functionality requires ongoing clinical guidance and education from providers.